President's Message
I am honoured to be elected as President of BASO~ACS from November
2021 for two years, the world's second oldest surgical society,
celebrating its 50th Anniversary this year. I first encountered
BASO as a surgical trainee in 2003 and presented a paper at the
BASO Conference, which was published in the EJSO (BASO's in-house
Journal). The organisation held interesting meetings, covering the
areas of cancer surgery that general surgical trainees had to
cover.
These meetings allowed insights into surgical cancer
treatments in other disciplines.
The majority of surgical cancer specialists have now been trained
totally in the era of subspecialty and apart from early experience
in a range of topics, have had a little senior experience of other
cancer management outside their own. One of the significant
benefits of being in BASO is that it allows the surgeons to hear
about cutting-edge research and cancer management in all solid
cancer surgical sites. Despite the separation of cancer type
management and many concepts, both surgical and adjuvant cross the
boundaries.
It is recognised, although not widely understood by the general
public or even those with responsibility for health matters, that
most cures for cancer are surgical, whether it's a simple resection
or a complex operation. As surgical treatment improves, we have to
ensure that the experience of surviving also enhances - the quality
of life is vitally important, and this is part of the surgical
ethos.
BASO~ACS is a charity, and our remit is to advance the science of
cancer surgery and to educate. We want to educate each other at a
senior level, to hear the best surgical talents in the world
discussing their work and expectations. We need to teach our
colleagues in training not only about research and the best
management of cancers but also to have an enquiring open mind -
because there will be significant changes during their working
lives. We can see the start of the genomic and robotic revolution,
but there are also the "unknown unknowns" that will affect the ways
of working for our the present trainees in 20 -30 years. BASO~ACS
works for the future of cancer research and treatment. As a
charity, we sponsor trainees' research, and we also send our stars
of the future to get an experience of the best surgical cancer
treatment in the world with the Ronald Raven Travelling Fellowship.
In addition, we have a very successful NIHR partnership which has
been culminated this year by the partnership with the Rosetrees
Trust to fund world-class quality cancer research projects up to
£50,000 per year for three years.
We have had four successful years of close links with the UK
Oncology Forum annual meetings and established a new successful
relationship with Oncology Professional Care (OPC) where we will
provide free CPD accredited entry to OPC annual conference. In
November 2022, we will be hosting our Annual Scientific Congress at
The Law Society which will be facilitated by international Keynote
speakers, workshops, as well as opportunities for trainees or
others to present their work in surgical oncology of all cancer
types to a broad audience. We encourage you to join us for this
Multidisciplinary Meeting which will focus on the evolving role of
surgical oncology.
BASO is also very proud to be one of the two founding bodies of
the European Journal of Surgical Oncology (EJSO). This Journal is
going from strength to strength under the leadership of Professor
Audisio with its impact factor exceeding this year and seeing a
steady rise in the number and quality of submissions. Subscription
to the Journal is a benefit of BASO~ACS membership.
We are fortunate that all our members benefit from our ongoing
close association with ESSO. Our trainees have access to all of the
Trainee events of EYSAC (European Young Surgeons and Alumni Club),
and BASO members benefit from member rates at all ESSO congresses
and courses across Europe as well as all the networking and
fellowship opportunities this linkage provides.
Finally we plan to increase our engagement with the national
community of cancer surgeons across the UK, both in academic,
teaching and district hospitals, by appointing regional
representatives across the UK. We must never lose sight of the fact
that the majority of cancers are dealt with by surgeons working in
smaller hospitals and we intent that BASO~ACS will continue to
support them in their work by providing first class continuing
medical education, networking and professional support.
We hope you will continue to support us as we move forward!
Mr Zaed Hamady
President BASO~ACS (2021-2023)
Senior Lecturer and Consultant Surgeon
University Hospitals Southampton NHS FT